Nigeria Warns Public as US Recalls Contaminated Children's Ibuprofen

Nigeria's National Agency for Food and Drug Administration and Control (NAFDAC) has issued a warning to healthcare providers, importers, and caregivers regarding a recall of Children's Ibuprofen Oral Suspension in the United States. The recall, initiated by Strides Pharma Inc., affects roughly 90,000 bottles due to concerns over contamination.

“

NAFDAC remains committed to safeguarding public health and will continue surveillance activities to ensure the quality, safety and efficacy of medicines circulating in Nigeria.

The US Food and Drug Administration announced the recall after receiving consumer complaints about a "gel-like mass" and "black particles" found in the oral suspension. This medication, commonly used for pain and fever relief in children, could pose health risks if contaminated. NAFDAC emphasized that foreign materials in medicines can compromise their quality, safety, and effectiveness, potentially leading to adverse reactions or choking hazards for children.

The affected product is Children's Ibuprofen Oral Suspension, USP, 100 mg/5 mL, manufactured in India for Taro Pharmaceuticals U.S.A., Inc. Specific batches with lot numbers 7261973A and 7261974A, expiring January 31, 2027, are included in the recall. These products were distributed nationwide in the US.

“

The agency also urged healthcare facilities to immediately inspect their inventories and quarantine any affected batches if identified.

Although the recall is limited to the US, NAFDAC is implementing precautionary measures to prevent the contaminated products from entering Nigeria through any channels. The agency has directed its zonal directors and state coordinators to enhance surveillance and remove any found products from circulation. NAFDAC urges importers, distributors, and healthcare professionals to source medical products only from authorized suppliers and advises parents and caregivers to immediately stop using the recalled product and seek medical attention if any unusual reactions occur.

“

Parents and caregivers who possess the recalled products, or who may have administered them to children, were advised to stop using them immediately and seek medical attention if any unusual reactions are observed.